"I would do whatever I needed to do to avoid that mirror, because it made me feel so bad." But after losing 80 pounds (and counting), the 35-year-old cardiac tech from Oklahoma can't wait for this year's Thanksgiving Day dinner
The answer depends on which GLP-1 receptor agonist you're using and whether it's a multi-dose pen or single-dose device
These insights, interpreted alongside your blood pressure response and clinical presentation, can support a more personalized conversation with your provider about optimal combined dosing and monitoring intensity
Importantly, consider the broader clinical picture
While people often believe that GLP-1s do all the work, its not true
Moreover, improvements in cardiac function resulting from treatment with GLP-1 receptor agonists may also contribute to the favorable kidney outcomes seen with these treatments by improving tissue perfusion (20)